Effect of Surgical Treatment for N2-Positive c-stage III Non-Small Cell Lung Carcinoma in the “PACIFIC” Era-Reference-Cited by-同舟云学术

Effect of Surgical Treatment for N2-Positive c-stage III Non-Small Cell Lung Carcinoma in the “PACIFIC” Era

Published:2023-12 Issue:8 Volume:24 Page:733-742
ISSN:1525-7304
Container-title:Clinical Lung Cancer
language:en
Short-container-title:Clinical Lung Cancer

Author:

Adachi Hiroyuki^ORCID,Ito Hiroyuki,Isaka Tetsuya,Murakami Kotaro,Miura Jun,Kikunishi Noritake,Shigeta Naoko,Saito Haruhiro,Yoshida Daisaku,Yokose Tomoyuki,Saito Aya

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference19 articles.

1. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods;Ferlay;Int J Cancer,2019

2. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer;Aupérin;J Clin Oncol,2010

3. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines), Non-small cell lung cancer. Version 5.2022. Accessed 17 October, 2022. Avalable at: https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf.

4. Five-year survival outcomes from the PACIFIC trial: durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer;Spigel;J Clin Oncol,2022

5. The IASLC lung cancer staging project: a proposal for a new international lymph node map in the forthcoming seventh edition of the TNM classification for lung cancer;Rusch;J Thorac Oncol,2009

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comments on “Effect of Surgical Treatment for N2-Positive c-Stage III Non–Small Cell Lung Carcinoma in the “PACIFIC” Era”;Clinical Lung Cancer;2023-11

2. Sufficient Multidisciplinary Discussion Can Make Patients’ Outcomes Better in the Treatment for Stage III Non–Small-Cell Lung Carcinoma - Reply to Ohri et al.;Clinical Lung Cancer;2023-11